Lowenstein Sandler has advised Sonnet BioTherapeutics Holdings. Greenberg Traurig has advised Hyperliquid Strategies Inc. Sonnet BioTherapeutics Holdings, an oncology-focused biotechnology company, has completed its business combination...
Sonnet BioTherapeutics Completes Business Combination with Hyperliquid Strategies
Sonnet BioTherapeutics and Rorschach I LLC Announce $888 Million HYPE Cryptocurrency Treasury Reserve Strategy
Lowenstein Sandler LLP has advised Sonnet BioTherapeutics, Inc. Greenberg Traurig, LLP has represented Rorschach I LLC. Sonnet BioTherapeutics, Inc. has entered into a definitive agreement to...
Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering
Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the...
Meta Materials’ $100 Million Common Stock Offering
Lowenstein Sandler represented the sales agents in the offering. Meta Materials Inc. announced its At-The-Market sales agreement for the issuance of up to $100 million of...